VMP 39733911000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Bosentan 125mg tablets
BNF code 0205010U0AAABAB
Virtual Therapeutic Moiety Bosentan
Date identifier became valid 27 May 2021
Previous product identifier 407816003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Bosentan monohydrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 385559004
Strength value numerator 125.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Bosentan 125mg tablets (Accord-UK Ltd)
Bosentan 125mg tablets (Cipla EU Ltd)
Bosentan 125mg tablets (Milpharm Ltd)
Bosentan 125mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Bosentan 125mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_10.0.0_20241007000001, imported on 7th October 2024 at 04:53:31.

Feedback